Filing Flows › Idexx Laboratories (IDXX) › Operating margin
Idexx Laboratories (IDXX) operating margin by quarter
Idexx Laboratories' operating margin was 33.1% in Q3 2026 (third quarter 2026), -1.8 pts from Q2 2026. Over the last 7 quarters it ranged from 28.9% (Q4 2025) to 35.0% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 33.1% | -1.8 pts | +1.0 pts |
| Q2 2026 | 35.0% | +3.2 pts | +1.4 pts |
| Q1 2026 | 31.8% | +2.8 pts | +0.1 pts |
| Q4 2025 | 28.9% | -3.2 pts | — |
| Q3 2025 | 32.1% | -1.5 pts | — |
| Q2 2025 | 33.6% | +1.9 pts | — |
| Q1 2025 | 31.7% | — | — |
Q3 2026 at a glance
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
What is Idexx Laboratories' operating margin?
Idexx Laboratories' operating margin was 33.1% in Q3 2026 (third quarter 2026), -1.8 pts from Q2 2026.
How has Idexx Laboratories' operating margin changed?
Over the last 7 quarters it ranged from 28.9% (Q4 2025) to 35.0% (Q2 2026).